Jacob E. Koskimaki, Ph.D.
Affiliations: | 2012 | Johns Hopkins University, Baltimore, MD |
Area:
Biomedical Engineering, Oncology, Bioinformatics BiologyGoogle:
"Jacob Koskimaki"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Aleksander S. Popel | grad student | 2012 | Johns Hopkins | |
| (Experimental and bioinformatic analysis of endogenous and mimetic anti-angiogenic peptides in application to cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lee E, Lee SJ, Koskimaki JE, et al. (2014) Inhibition of breast cancer growth and metastasis by a biomimetic peptide. Scientific Reports. 4: 7139 |
| Rosca EV, Penet MF, Mori N, et al. (2014) A biomimetic collagen derived peptide exhibits anti-angiogenic activity in triple negative breast cancer. Plos One. 9: e111901 |
| Shmueli RB, Ohnaka M, Miki A, et al. (2013) Long-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptide. Biomaterials. 34: 7544-51 |
| Lee E, Koskimaki JE, Pandey NB, et al. (2013) Inhibition of lymphangiogenesis and angiogenesis in breast tumor xenografts and lymph nodes by a peptide derived from transmembrane protein 45A. Neoplasia (New York, N.Y.). 15: 112-24 |
| Koskimaki JE, Lee E, Chen W, et al. (2013) Synergy between a collagen IV mimetic peptide and a somatotropin-domain derived peptide as angiogenesis and lymphangiogenesis inhibitors. Angiogenesis. 16: 159-70 |
| Koskimaki JE, Rosca EV, Rivera CG, et al. (2012) Serpin-derived peptides are antiangiogenic and suppress breast tumor xenograft growth. Translational Oncology. 5: 92-7 |
| Rosca EV, Lal B, Koskimaki JE, et al. (2012) Collagen IV and CXC chemokine-derived antiangiogenic peptides suppress glioma xenograft growth. Anti-Cancer Drugs. 23: 706-12 |
| Rosca EV, Koskimaki JE, Pandey NB, et al. (2012) Structure-activity relationship study of collagen-derived anti-angiogenic biomimetic peptides. Chemical Biology & Drug Design. 80: 27-37 |
| Rosca EV, Koskimaki JE, Pandey NB, et al. (2011) Development of a biomimetic peptide derived from collagen IV with anti-angiogenic activity in breast cancer. Cancer Biology & Therapy. 12: 808-17 |
| Rivera CG, Rosca EV, Pandey NB, et al. (2011) Novel peptide-specific quantitative structure-activity relationship (QSAR) analysis applied to collagen IV peptides with antiangiogenic activity. Journal of Medicinal Chemistry. 54: 6492-500 |